BREAKING
Dogwood Therapeutics (DWTX) Q4 Loss Narrows to $0.26, Beats Estimates 5 hours ago General Mills (GIS) Q3 EPS Misses by 12% at $0.64 as Revenue Falls 8% YoY to $4.44B 5 hours ago Star Equity Holdings Slips to a Loss in Q4 FY25; Revenue Surges 69% to $56.8M 5 hours ago Ovid Therapeutics (OVID) Swings to $0.06 EPS in Q4 FY25 6 hours ago Giftify, Inc. (GIFT) Narrows Loss Q4 EPS Estimates by 11.0% 6 hours ago Weibo Corporation (WB) Misses Q4 EPS Estimates 6 hours ago ADMA CEO Adam Grossman Sells 15,000 Shares at $15.16 Amid 125K Share Insider Selloff 6 hours ago AESI CEO Forfeits Shares at $13.60 as Six-Month Insider Selling Trend Reaches 582,124 Shares 6 hours ago Ulta Beauty CEO Kecia Steelman Surrenders 1,491 Shares at $535.72 in Tax Withholding Transaction 7 hours ago BLDR CEO Peter Jackson and 7 Executives Surrender $2.77M in Shares for Tax Withholdings 7 hours ago Dogwood Therapeutics (DWTX) Q4 Loss Narrows to $0.26, Beats Estimates 5 hours ago General Mills (GIS) Q3 EPS Misses by 12% at $0.64 as Revenue Falls 8% YoY to $4.44B 5 hours ago Star Equity Holdings Slips to a Loss in Q4 FY25; Revenue Surges 69% to $56.8M 5 hours ago Ovid Therapeutics (OVID) Swings to $0.06 EPS in Q4 FY25 6 hours ago Giftify, Inc. (GIFT) Narrows Loss Q4 EPS Estimates by 11.0% 6 hours ago Weibo Corporation (WB) Misses Q4 EPS Estimates 6 hours ago ADMA CEO Adam Grossman Sells 15,000 Shares at $15.16 Amid 125K Share Insider Selloff 6 hours ago AESI CEO Forfeits Shares at $13.60 as Six-Month Insider Selling Trend Reaches 582,124 Shares 6 hours ago Ulta Beauty CEO Kecia Steelman Surrenders 1,491 Shares at $535.72 in Tax Withholding Transaction 7 hours ago BLDR CEO Peter Jackson and 7 Executives Surrender $2.77M in Shares for Tax Withholdings 7 hours ago

Featured

Transcript $MU Q2 2026

Micron Technology, Inc Earnings Call Transcript

Micron Technology, Inc (NASDAQ: MU) Q2 2026 Earnings Call dated Mar. 18, 2026 Corporate Participants: Satya Kumar — Investor Relations...

26 minutes ago
Breaking News 5 hours ago

Dogwood Therapeutics (DWTX) Q4 Loss Narrows to $0.26, Beats Estimates

Dogwood Therapeutics posts Q4 loss of $0.26/share, 69.8% narrower than the $0.86 consensus, as clinical-stage biotech reduces burn rate.

Trending Now

Latest Transcripts

Live
View All

Market News

View All